Pfizer $5.2 billion acquisition of Anacor Pharmaceuticals

Overview:

• Pfizer has acquired Anacor Pharmaceuticals for $5.2 billion.
• The deal comes in the wake of a failed bid by Pfizer for Allergan in early April.
• Wachtell Lipton Rosen & Katz (Edward Herlihy, David Lam, Alison Zieske) advised Pfizer.
• Davis Polk & Wardwell (Michael Davis, H Oliver Smith) advised Anacor.

Kurt Stumpo - Journalist - North America and the Caribbean